Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
猴头健胃灵胶囊 (Houtou Jianweiling Jiaonang) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Shanxi Wanglong Pharmaceutical Group. It is an oral capsule indicated for the treatment of digestive system disorders, including chronic gastritis, gastric and duodenal ulcers, and symptoms such as gastric distention, pain, vomiting, and acid regurgitation associated with liver-stomach disharmony. The formulation consists of six herbal ingredients: *Hericium erinaceus* mycelium, cuttlefish bone, processed *Corydalis yanhusuo*, wine-processed white peony root, vinegar-processed *Cyperus*, and licorice. These components work synergistically to support digestive function and protect the gastric mucosa, though no single molecular target is identified. It is approved in China under the drug approval number 国药准字Z14020754.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 猴头健胃灵胶囊.